Helen Rizos


  • 3576 Citations
  • 36 h-Index
1989 …2022
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Helen Rizos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tumor Suppressor Protein p14ARF Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Mutation Medicine & Life Sciences
Tumors Chemical Compounds
Melanocytes Medicine & Life Sciences
Mitogen-Activated Protein Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2022

Centre of Research Excellence in Melanoma: Person, tumour and system-focussed knowledge to drive better outcomes in melanoma

Braithwaite, J., Mann, G. J., Cust, A. E., Scolyer, R. A., Kelly, J., Morton, R. L., Spillane, A. J., Saw, R., Henderson, M., Yang, J. Y. H., Hong, A., Tran, A., Gyorki, D., Milne, D., Long, G. V., Rizos, H., Kasparian, N., Fernández-Peñas, P. & Guitera, P.


Project: Other

Determinants of response to immune checkpoint inhibitors in melanoma

Rizos, H., Long, G., Menzies, A. M., Yang, J., Carlino, M., Kefford, R., Scolyer, R., MQRES, M., MQRES 3 (International), M. 3. & De St Groth, B. F.

1/01/17 → …

Project: Research

Research Outputs 1989 2019

Analysis of the whole-exome sequencing of tumor and circulating tumor DNA in metastatic melanoma

Diefenbach, R. J., Lee, J. H., Strbenac, D., Yang, J. Y. H., Menzies, A. M., Carlino, M. S., Long, G. V., Spillane, A. J., Stretch, J. R., Saw, R. P. M., Thompson, J. F., Ch'ng, S., Scolyer, R. A., Kefford, R. F. & Rizos, H., 29 Nov 2019, In : Cancers. 11, 12, p. 1-14 14 p., 1905.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1 based immunotherapy

Lim, S. Y., Lee, J. H., Nur Gide, T., Menzies, A. M., Guminski, A., Carlino, M. S., Breen, E., Yang, J. Y. H., Ghazanfar, S., Kefford, R. F., Scolyer, R. A., Long, G. V. & Rizos, H., Mar 2019, In : Clinical Cancer Research. 25, 5, p. 1557-1563 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Confidence Intervals

Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1/anti-CTLA-4 combined therapy

Gide, T. N., Quek, C., Menzies, A. M., Tasker, A. T., Shang, P., Holst, J., Madore, J., Lim, S. Y., Velickovic, R., Wongchenko, M., Yan, Y., Lo, S., Carlino, M. S., Guminski, A., Saw, R. P. M., Pang, A., McGuire, H. M., Palendira, U., Thompson, J. F., Rizos, H. & 5 othersSilva, I. P. D., Batten, M., Scolyer, R. A., Long, G. V. & Wilmott, J. S., 11 Feb 2019, In : Cancer Cell. 35, 2, p. 238-255.e6 24 p.

Research output: Contribution to journalArticleResearchpeer-review


Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma

da Silva, I. P., Wang, K. Y. X., Wilmott, J. S., Holst, J., Carlino, M. S., Park, J. J., Quek, C., Wongchenko, M., Yan, Y., Mann, G., Johnson, D. B., McQuade, J. L., Rai, R., Kefford, R. F., Rizos, H., Scolyer, R. A., Yang, J. Y. H., Long, G. V. & Menzies, A. M., 15 Feb 2019, In : Clinical Cancer Research. 25, 4, p. 1272-1279 8 p.

Research output: Contribution to journalArticleResearchpeer-review

MAP Kinase Signaling System
Dual Specificity Phosphatase 6

Emerging novel therapies in overcoming resistance to targeted therapy

Pinho, A. V., Lee, J. H. & Rizos, H., 2019, Current applications for overcoming resistance to targeted therapies. Szewczuk, M. R., Qorri, B. & Sambi, M. (eds.). Switzerland: Springer, Springer Nature, p. 223-258 36 p. (Resistance to Targeted Anti-Cancer Therapeutics; vol. 20).

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

Physiologic Monitoring
Leukemia, Myelogenous, Chronic, BCR-ABL Positive